Health and Healthcare
Boston Scientific And Johnson & Johnson: Stents Make A Comeback?
Published:
http://www.bloomberg.com/apps/news?pid=20601087&sid=ajZ2lVrqeb2I&refer=homeA study out fo Sweden may help the flagging fortunes of the stent businesses at Boston Scientific (BSX) and Johnsohn & Johnson (JNJ). Several pieces of research had indicated that drug-coated stents could cause cloating and health risks.
According to Bloomberg, "The new findings, presented at the European Society of Cardiology meeting in Vienna, show patients getting the drug- coated stents weren’t more likely to die or have a heart attack than those given the older, bare-metal stents." The use of blood thinners may have aided the results.
A number of doctors remain unconvinced.
Share of BSX has been badly hurt by the controversy of stent safety. The company is looking at selling division to save money and some Wall St. analysts think the company may run into cash flow problems while it pays down its huge debt, brought on when it bought medical device company Guidant.
BSX shares were above $28 in late 2005. Today they trade below $13.
Douglas A. McIntyre
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
